These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 16362986

  • 1. Rational design of gene-based vaccines.
    Barouch DH.
    J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors.
    Seregin SS, Amalfitano A.
    Expert Opin Biol Ther; 2009 Dec; 9(12):1521-31. PubMed ID: 19780714
    [Abstract] [Full Text] [Related]

  • 4. Advances in the development of bacterial vector technology.
    Kochi SK, Killeen KP, Ryan US.
    Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
    [Abstract] [Full Text] [Related]

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Immunity and EGFPC3 expression of recombinant attenuated salmonella typhimurium carrying plasmid pcDNA3s and EGFPC3 in mice].
    Fang XX, Wang DM, Shi YH, LE GW, Bai XP, Liu JW.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):299-302. PubMed ID: 17428380
    [Abstract] [Full Text] [Related]

  • 9. DNA vaccines: vector design, delivery, and antigen presentation.
    Feltquate DM.
    J Cell Biochem Suppl; 1998 Apr; 30-31():304-11. PubMed ID: 9893284
    [Abstract] [Full Text] [Related]

  • 10. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S, Feng X, Shu T, Matano T, Hasegawa M, Wang X, Ma H, Li H, Li Z, Zeng Y.
    Vaccine; 2008 Nov 11; 26(48):6124-31. PubMed ID: 18812199
    [Abstract] [Full Text] [Related]

  • 11. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA.
    Curr Opin Mol Ther; 2003 Feb 11; 5(1):10-9. PubMed ID: 12669465
    [Abstract] [Full Text] [Related]

  • 12. From plasmids to protection: a review of DNA vaccines against infectious diseases.
    Laddy DJ, Weiner DB.
    Int Rev Immunol; 2006 Feb 11; 25(3-4):99-123. PubMed ID: 16818367
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques.
    Takeda A, Igarashi H, Kawada M, Tsukamoto T, Yamamoto H, Inoue M, Iida A, Shu T, Hasegawa M, Matano T.
    Vaccine; 2008 Dec 09; 26(52):6839-43. PubMed ID: 18930099
    [Abstract] [Full Text] [Related]

  • 14. DNA vaccines.
    Donnelly JJ, Ulmer JB, Shiver JW, Liu MA.
    Annu Rev Immunol; 1997 Dec 09; 15():617-48. PubMed ID: 9143702
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design of plasmid DNA constructs for vaccines.
    Montgomery DL, Prather KJ.
    Methods Mol Med; 2006 Dec 09; 127():11-22. PubMed ID: 16988443
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.